Clinical Trial Update: Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating risperidone as monotherapy in adults with bipolar disorder and concurrent anxiety disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorder
• Bipolar Disorder

Drugs mentioned

• Risperdal (risperidone)

Snippet

Sponsor: Lindner Center of HOPE | Conditions: Bipolar Disorder, Anxiety Disorder | Phase 3 | Status: COMPLETED